Syncope, a transient loss of consciousness due to cerebral hypoperfusion, presents a diagnostic puzzle due to its multifactorial etiology. This article aims to provide a comprehensive approach to its diagnosis and management in clinical practice.
Accurate diagnosis of syncope requires a detailed history, physical examination, and selective use of diagnostic tests. History should focus on the circumstances preceding the event, presence of prodromal symptoms, and post-event recovery. Physical examination should include orthostatic blood pressure measurements and a cardiovascular examination. Electrocardiogram (ECG) is the most useful initial diagnostic test. Further testing, such as echocardiography or tilt-table testing, should be guided by clinical suspicion.
Syncope can be classified into three broad categories: reflex (neurally-mediated), orthostatic hypotension, and cardiac. Reflex syncope, the most common type, includes vasovagal, situational, and carotid sinus hypersensitivity. Orthostatic hypotension, often drug-induced, necessitates a review of the patient's medication. Cardiac syncope, the most serious type, often indicates underlying structural heart disease or arrhythmia.
Management of syncope should be tailored to the underlying cause. Reflex syncope can often be managed with patient education and lifestyle modifications. Orthostatic hypotension may necessitate medication changes. Cardiac syncope often requires specialist referral for potential interventions such as pacemaker implantation or cardiac surgery.
While syncope is generally benign, it can be a marker of serious underlying disease. Prognosis largely depends on the underlying cause, with cardiac syncope associated with a significantly worse prognosis. Regular follow-up is crucial to monitor for potential complications.
As clinicians, we are often faced with the challenge of diagnosing and managing syncope. By adopting a comprehensive approach, we can better identify the underlying cause, guide appropriate management, and improve patient outcomes.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation